 SOUTH SAN FRANCISCO, Calif., March 31, 2021 GLOBE NEWSWIRE -- Applied Molecular Transport Inc. Nasdaq: AMTI AMT, a clinical-stage biopharmaceutical company, today announced the pricing of an underwritten public offering of 2,500,000 shares of its common stock at a public offering price of 42.00 per share. All of the shares of common stock are being offered by AMT. In addition, AMT has granted the underwriters a 30-day option to purchase up to an additional 375,000 shares of its common stock at the public offering price, less the underwriting discounts and commissions. The gross proceeds to AMT from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by AMT, are expected to be 105.0 million, excluding any exercise of the underwriters option to purchase additional shares. The offering is expected to close on April 6, 2021, subject to the satisfaction of customary closing conditions. 